Analysts Set Simulations Plus, Inc. (NASDAQ:SLP) Price Target at $49.40

Shares of Simulations Plus, Inc. (NASDAQ:SLP) have received a consensus rating of “Buy” from the seven brokerages that are covering the firm, MarketBeat Ratings reports. One investment analyst has rated the stock with a hold recommendation, five have issued a buy recommendation and one has issued a strong buy recommendation on the company. The average 1 year price target among brokers that have covered the stock in the last year is $49.40.

A number of research firms have recently commented on SLP. William Blair restated an “outperform” rating on shares of Simulations Plus in a report on Wednesday, January 8th. KeyCorp upped their target price on shares of Simulations Plus from $35.00 to $37.00 and gave the stock an “overweight” rating in a research note on Friday, January 24th.

Insider Buying and Selling at Simulations Plus

In other Simulations Plus news, Director Walter S. Woltosz sold 20,000 shares of the stock in a transaction on Monday, February 3rd. The stock was sold at an average price of $33.91, for a total transaction of $678,200.00. Following the sale, the director now owns 3,402,584 shares of the company’s stock, valued at approximately $115,381,623.44. This trade represents a 0.58 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Insiders own 19.40% of the company’s stock.

Institutional Investors Weigh In On Simulations Plus

A number of hedge funds have recently made changes to their positions in the stock. Janus Henderson Group PLC boosted its stake in Simulations Plus by 7,753.3% in the fourth quarter. Janus Henderson Group PLC now owns 542,899 shares of the technology company’s stock valued at $15,141,000 after acquiring an additional 535,986 shares in the last quarter. Conestoga Capital Advisors LLC grew its stake in Simulations Plus by 15.0% during the 4th quarter. Conestoga Capital Advisors LLC now owns 2,226,262 shares of the technology company’s stock worth $62,090,000 after buying an additional 290,414 shares during the last quarter. Royce & Associates LP increased its position in Simulations Plus by 56.6% during the 4th quarter. Royce & Associates LP now owns 371,797 shares of the technology company’s stock valued at $10,369,000 after buying an additional 134,381 shares in the last quarter. Nicholas Company Inc. purchased a new stake in Simulations Plus in the fourth quarter valued at about $3,418,000. Finally, Kennedy Capital Management LLC boosted its holdings in Simulations Plus by 59.4% in the fourth quarter. Kennedy Capital Management LLC now owns 289,286 shares of the technology company’s stock worth $8,068,000 after acquiring an additional 107,766 shares in the last quarter. 78.08% of the stock is currently owned by hedge funds and other institutional investors.

Simulations Plus Stock Up 0.8 %

SLP opened at $24.20 on Friday. The business has a fifty day moving average of $30.92 and a 200 day moving average of $30.63. Simulations Plus has a 52-week low of $23.63 and a 52-week high of $51.22. The stock has a market cap of $486.23 million, a P/E ratio of 60.50 and a beta of 0.89.

Simulations Plus Company Profile

Simulations Plus, Inc develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through two segments, Software and Services. It offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products.